Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-02-20
1993-03-16
Lee, Mary C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514321, 514322, 514323, 514324, 514362, 544 8, 546209, 546271, 546273, 546274, 546280, 548134, A61K 31445, C07D41702, C07D28516, C07D28510
Patent
active
051944405
ABSTRACT:
A class of substituted cyclic sulphamide derivatives are selective agonists of 5-HT.sub.1 -like receptors and are therefore useful in the treatment of clinical conditions, in particular migraine and associated disorders, for which a selective agonist of these receptors is indicated.
REFERENCES:
patent: 4692531 (1987-09-01), Algieri et al.
A. Doenicke, et al The Lancet, 1988, 1, 1309-11.
Design of Prodrugs, ed. H. Bundgaard, Elsevier, 1985.
Indian J. Chem., 1982, 21B, 941.
Chem. Ber., 1978, 111, 1915.
Protective Groups in Organic Chemistry, ed. J. F. W. McOmie, Plenum Press, 1973.
Protective Groups in Organic Synthesis, John Wiley & Sons, 1981.
J. Neurosci., 1987, 7, 894.
Arch. Pharm., 1990, 342, 111.
J. Org. Chem., 1982, 47 536.
Caruso Charles M.
Lee Mary C.
McKane Jospeh K.
Merck Sharp & Dohme Ltd.
Polk Manfred
LandOfFree
Substituted cyclic sulphamide derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted cyclic sulphamide derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted cyclic sulphamide derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-350714